Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD
Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD
Not yet recruiting · NCT07178249 · Registry updated 2025-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD | Wet Age-related Macular Degeneration | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-17 | NCT07178249 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangzhou Jiayin Biotech Ltd | 6 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||